Related Experiment Video

Updated: Nov 2, 2025

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.0K

Radiation recall myositis caused by pazopanib in a patient with refractory osteosarcoma

Takuya Kosaka1, Megumi Uto1, Shinya Hiraoka1

  • 1Department of Radiation Oncology and Image-Applied Therapy, Kyoto University, Kyoto, Japan.

Pediatric Blood & Cancer
|June 14, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.5K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.9K

Related Experiment Videos

Last Updated: Nov 2, 2025

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.0K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.5K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.9K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.7K

Articles linked to this work by shared authors, journal, and citation graph.

Development of CBCT-Guided Online Adaptive Radiotherapy.

Cancers·2026

Dual Aberrant Splicing Caused by an Apparently Missense CHD7 Variant, c.5273A>G (p.Asp1758Gly), in CHARGE Syndrome.

American journal of medical genetics. Part A·2026

Lower social participation and physical activity in patients with craniopharyngioma or CNS germ cell tumor: Their association with apathy.

PCN reports : psychiatry and clinical neurosciences·2026

Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Feasibility and Efficacy of Lorlatinib in Japanese Patients With Relapsed/Refractory ALK-Aberrant Neuroblastoma.

Pediatric blood & cancer·2026

Personalized reference genome-based pipeline reveals comprehensive haplotype-resolved views of cancer genomes.

bioRxiv : the preprint server for biology·2026

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab.

Pediatric blood & cancer·2026

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation.

Pediatric blood & cancer·2026

Bone Marrow and Lymph Node Involvement in Newly Diagnosed Pediatric Rhabdomyosarcoma: Can 18F-FDG PET/CT Replace Bone Marrow and Lymph Node Biopsies? Analysis of the "Paris Kids Cancer" Cohort.

Pediatric blood & cancer·2026

Evidence-Informed Multidisciplinary Consensus Guidance for the Psychosocial Care of Adolescents With High-Risk Cancer: Recommendations From the Italian Association of Pediatric Hematology and Oncology.

Pediatric blood & cancer·2026

The Impact of the COVID-19 Pandemic on Childhood Cancer Survival: A Population-Based Assessment of Survival Patterns Between 2015 and 2023 in Germany.

Pediatric blood & cancer·2026

Comparative Effectiveness of Antibiotic Prophylaxis Regimens in Pediatric Acute Myeloid Leukemia.

Pediatric blood & cancer·2026

A case of recurrent acute acalculous cholecystitis in a patient with renal cell carcinoma treated with pazopanib and axitinib: case report and literature review.

Frontiers in pharmacology·2026

Efficacy and cosmetic outcomes of radiotherapy modalities in early-stage breast cancer: a systematic review and network meta-analysis.

Frontiers in oncology·2026

Rac1 and CHK1 Converge on Abi-1 to Regulate DNA Repair Dependency and Treatment Response in Human Cancers.

bioRxiv : the preprint server for biology·2026

Early-Onset Radiation-Induced Angiosarcoma of the Breast: A Case Report and Literature Review.

European journal of breast health·2026

Dose equivalence calculation in radiotherapy: A Call for Standardization.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026

SCOPES-II: short course of preoperative radiotherapy in head and neck, trunk and extremity soft tissue sarcomas - study protocol for a second randomised phase II clinical trial.

BMJ open·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us